Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

Vall d’Hebron is part of the Consorcio INTERCOVID, which has analyzed over 6,500 pregnancies in 18 countries and observed a significant reduction in the risk of preeclampsia associated with vaccination.

The document provides a comprehensive evaluation of current knowledge on this type of cancer affecting the bile ducts.

The initiative aims to transform and improve how clinical trials are conducted in the field of rare diseases.

The charitable initiative will allocate all funds to research on pediatric nervous system tumors carried out at the Vall d’Hebron Research Institute

A large-scale study involving Vall d’Hebron confirms the genetic relatedness among 14 different psychiatric disorders and groups them into five new families, paving the way for new treatments targeting their shared underlying genetic causes

The study, led by Dr. Lucas Moreno and University of Birmingham shows that the combined administration of chemotherapy and immunotherapy with the antibody dinutuximab beta achieves a better treatment response.

The donation will support a project investigating new therapeutic approaches in pediatric brain tumors

The €15,000 donation will boost research into this very rare type of childhood cancer.

On the occasion of the International Day of Women and Girls in Science, celebrated every 11 February, around one hundred children aged between 10 and 12 have discovered the laboratories of the VHIR.

The association has donated €15,088 to the Childhood Cancer and Blood Disorders group at VHIR to improve the treatment of rhabdomyosarcoma.

The Iris Association has made a €14,499 donation to the Childhood Cancer and Hematological Diseases Group at the Vall d’Hebron Research Institute (VHIR).

Vall d’Hebron has taken part in a clinical trial whose results show improvements in endometrial regeneration and reproductive outcomes in patients with Asherman syndrome who had not responded to previous surgery.

A VHIR team travels to Angola to test, under real-world conditions, an innovative device designed for mass diagnosis in resource-limited settings.

This VHIR initiative promotes well-being, empathy and community participation in Barcelona neighbourhoods through an intergenerational model

The donation raised through ALS, the Musical will support the development of new biomarkers and more personalised research into the disease

The results show that diet induces changes in the gut microbiota that differ between Crohn’s disease and ulcerative colitis, and that influence levels of intestinal inflammation.

The paper describes the case of a patient in whom, years after a bone marrow transplant, two immune cell lines corrected the original genetic defect.

The funds raised will contribute to ensuring the continuity of the pediatric brain tumor research line developed by the Vall d’Hebron research teams.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

The study analyzes a new therapeutic strategy in high-risk patients that could influence future international clinical guidelines

Amb 387 procediments practicats, l’Hospital Vall d’Hebron es consolida al capdavant dels centres capacitats per realitzar trasplantaments en adults i pediàtrics.

The report, published in Nature, reveals that polyamines bind to specific domains in proteins and operate as a metabolic shield against modifications in their structure.

You can now pre-register for the Master’s Degree in Translational Biomedical Research, the Master’s in Health Innovation and Entrepreneurship, and the Master’s in Clinical Trials Management and Coordination.

During the annual meeting, representatives from the different centers participating in the project shared the progress made across the various areas of work.